trial

Mindfulness Group-based Intervention for Early Psychosis

NCTId NCT03143907
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 70 (actual)
Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Primary completion 2020-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
70 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2018-02-22
Primary completion
2020-05-31
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
Mindfulness Ambassador Council for Early Psychosis (MAC-EP)

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sLead Sponsor
University of Western Ontario, CanadaCollaborator
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sCollaborator
Mindfulness Without BordersCollaborator

Investigators

1
Arlene MacDougall, M.Sc., M.D.Principal Investigator

Sites

5 total
Chatham, CanadaGuelph, CanadaHamilton, CanadaLondon, CanadaSarnia, Canada

Facts & assertions

4 sourced
Enrollment
70
Phase
NA
Primary Completion Date
2020-05-31
Status
COMPLETED
relationships
The graph out of here
drug
Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
drug
lead_sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
company
collaborator
University of Western Ontario, Canada
company
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
company
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Arlene MacDougall, M.Sc., M.D.
person